Beam Therapeutics IncNASDAQ:BEAM
- LAST PRICE24.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots24.2600/ 1
- Ask / Lots24.6500/ 1
- Open / Previous Close--- / 24.0500
- Day Range---
- 52 Week Range
- Volume4,902
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BEAM |
|---|---|---|
| 09:32 ET | 26054 | 26.275 |
| 09:33 ET | 2105 | 25.72 |
| 09:35 ET | 8018 | 25.82 |
| 09:37 ET | 7534 | 25.37 |
| 09:39 ET | 19748 | 25.15 |
| 09:42 ET | 4569 | 25.04 |
| 09:44 ET | 3226 | 25.19 |
| 09:46 ET | 4027 | 25.07 |
| 09:48 ET | 9066 | 25.03 |
| 09:50 ET | 2233 | 25.25 |
| 09:51 ET | 1874 | 25.26 |
| 09:53 ET | 2670 | 25.31 |
| 09:55 ET | 1000 | 25.315 |
| 09:57 ET | 1000 | 25.3 |
| 10:00 ET | 2692 | 25.11 |
| 10:02 ET | 1400 | 25.14 |
| 10:04 ET | 1925 | 25.115 |
| 10:06 ET | 1235 | 24.98 |
| 10:08 ET | 2658 | 25.195 |
| 10:09 ET | 2935 | 25.09 |
| 10:11 ET | 1952 | 25.18 |
| 10:13 ET | 2129 | 25.03 |
| 10:15 ET | 1887 | 25.1434 |
| 10:18 ET | 3027 | 25.11 |
| 10:20 ET | 1900 | 25.02 |
| 10:22 ET | 2210 | 25.03 |
| 10:24 ET | 6484 | 25 |
| 10:26 ET | 6491 | 24.965 |
| 10:27 ET | 11475 | 25.15 |
| 10:29 ET | 12391 | 25.01 |
| 10:31 ET | 4463 | 24.9 |
| 10:33 ET | 1198 | 24.805 |
| 10:36 ET | 2456 | 24.725 |
| 10:38 ET | 1800 | 24.6491 |
| 10:40 ET | 5626 | 24.72 |
| 10:42 ET | 3109 | 24.665 |
| 10:44 ET | 1758 | 24.65 |
| 10:45 ET | 2762 | 24.6 |
| 10:47 ET | 9309 | 24.43 |
| 10:49 ET | 3687 | 24.53 |
| 10:51 ET | 5269 | 24.53 |
| 10:54 ET | 13021 | 24.28 |
| 10:56 ET | 3124 | 24.19 |
| 10:58 ET | 9966 | 24.2 |
| 11:00 ET | 13159 | 24.11 |
| 11:02 ET | 28572 | 23.94 |
| 11:03 ET | 43568 | 23.84 |
| 11:05 ET | 7377 | 23.65 |
| 11:07 ET | 10782 | 23.78 |
| 11:09 ET | 7157 | 23.855 |
| 11:12 ET | 7299 | 23.8401 |
| 11:14 ET | 26990 | 23.785 |
| 11:16 ET | 38387 | 23.865 |
| 11:18 ET | 11320 | 23.94 |
| 11:20 ET | 4309 | 23.84 |
| 11:21 ET | 15858 | 24.13 |
| 11:23 ET | 6824 | 24.27 |
| 11:25 ET | 6036 | 24.35 |
| 11:27 ET | 38189 | 24.13 |
| 11:30 ET | 6545 | 24.17 |
| 11:32 ET | 9136 | 24.02 |
| 11:34 ET | 1753 | 24.0963 |
| 11:36 ET | 2434 | 24.0075 |
| 11:38 ET | 13654 | 23.965 |
| 11:39 ET | 3900 | 23.93 |
| 11:41 ET | 7276 | 23.86 |
| 11:43 ET | 4442 | 23.91 |
| 11:45 ET | 1000 | 23.96 |
| 11:48 ET | 1119 | 24.005 |
| 11:50 ET | 3023 | 23.92 |
| 11:52 ET | 3029 | 24 |
| 11:54 ET | 31324 | 23.85 |
| 11:56 ET | 3426 | 24.02 |
| 11:57 ET | 2327 | 24.13 |
| 11:59 ET | 5769 | 24.15 |
| 12:01 ET | 1178 | 24.11 |
| 12:03 ET | 1936 | 24 |
| 12:06 ET | 1859 | 23.99 |
| 12:08 ET | 2270 | 23.76 |
| 12:10 ET | 3032 | 23.74 |
| 12:12 ET | 907 | 23.675 |
| 12:14 ET | 2713 | 23.69 |
| 12:15 ET | 6611 | 23.87 |
| 12:17 ET | 1900 | 23.905 |
| 12:19 ET | 1900 | 23.98 |
| 12:21 ET | 2600 | 23.86 |
| 12:24 ET | 1186 | 23.83 |
| 12:26 ET | 2548 | 23.84 |
| 12:28 ET | 1429 | 23.86 |
| 12:30 ET | 3049 | 23.93 |
| 12:32 ET | 3735 | 23.905 |
| 12:33 ET | 4661 | 23.89 |
| 12:35 ET | 600 | 23.855 |
| 12:37 ET | 6215 | 23.95 |
| 12:39 ET | 3100 | 23.91 |
| 12:42 ET | 937 | 23.97 |
| 12:44 ET | 1100 | 23.89 |
| 12:46 ET | 3628 | 24.025 |
| 12:48 ET | 1905 | 23.96 |
| 12:50 ET | 1457 | 23.97 |
| 12:51 ET | 2128 | 24 |
| 12:53 ET | 2588 | 24.12 |
| 12:55 ET | 9316 | 24.2 |
| 12:57 ET | 3442 | 24.2766 |
| 01:00 ET | 7170 | 24.29 |
| 01:02 ET | 6686 | 24.31 |
| 01:04 ET | 1800 | 24.25 |
| 01:06 ET | 4840 | 24.25 |
| 01:08 ET | 10894 | 24.26 |
| 01:09 ET | 400 | 24.32 |
| 01:11 ET | 6770 | 24.26 |
| 01:13 ET | 4612 | 24.265 |
| 01:15 ET | 784 | 24.26 |
| 01:18 ET | 11385 | 24.26 |
| 01:20 ET | 3804 | 24.2 |
| 01:22 ET | 3615 | 24.22 |
| 01:24 ET | 709 | 24.24 |
| 01:26 ET | 6797 | 24.24 |
| 01:27 ET | 3711 | 24.24 |
| 01:29 ET | 871 | 24.26 |
| 01:31 ET | 1133 | 24.28 |
| 01:33 ET | 1772 | 24.25 |
| 01:36 ET | 1200 | 24.28 |
| 01:38 ET | 3665 | 24.26 |
| 01:40 ET | 2487 | 24.285 |
| 01:42 ET | 100 | 24.27 |
| 01:44 ET | 2009 | 24.26 |
| 01:45 ET | 1730 | 24.265 |
| 01:47 ET | 482 | 24.285 |
| 01:49 ET | 1233 | 24.25 |
| 01:51 ET | 4838 | 24.35 |
| 01:54 ET | 900 | 24.35 |
| 01:56 ET | 3765 | 24.35 |
| 01:58 ET | 1353 | 24.36 |
| 02:00 ET | 3776 | 24.38 |
| 02:02 ET | 4144 | 24.515 |
| 02:03 ET | 51190 | 24.3901 |
| 02:05 ET | 870 | 24.365 |
| 02:07 ET | 2690 | 24.395 |
| 02:09 ET | 1215 | 24.44 |
| 02:12 ET | 1200 | 24.4 |
| 02:14 ET | 3873 | 24.375 |
| 02:16 ET | 4142 | 24.21 |
| 02:18 ET | 2547 | 24.13 |
| 02:21 ET | 2374 | 24.1 |
| 02:23 ET | 2110 | 24.075 |
| 02:25 ET | 5967 | 24.095 |
| 02:27 ET | 1315 | 24.11 |
| 02:30 ET | 4257 | 24.03 |
| 02:32 ET | 22123 | 24.075 |
| 02:34 ET | 2826 | 24.13 |
| 02:36 ET | 22300 | 24.14 |
| 02:38 ET | 5346 | 24.125 |
| 02:39 ET | 19747 | 24.14 |
| 02:41 ET | 8128 | 24.1 |
| 02:43 ET | 401 | 24.13 |
| 02:45 ET | 100 | 24.13 |
| 03:14 ET | 5391 | 24 |
| 03:15 ET | 5229 | 24.02 |
| 03:17 ET | 5176 | 24.02 |
| 03:19 ET | 6132 | 23.975 |
| 03:21 ET | 6027 | 23.93 |
| 03:24 ET | 1727 | 23.9197 |
| 03:26 ET | 1869 | 24 |
| 03:28 ET | 13675 | 24.05 |
| 03:30 ET | 1980 | 24.04 |
| 03:32 ET | 5157 | 24.08 |
| 03:33 ET | 4445 | 24.08 |
| 03:35 ET | 1106 | 24.055 |
| 03:37 ET | 6152 | 24.16 |
| 03:39 ET | 5393 | 24.15 |
| 03:42 ET | 3953 | 24.155 |
| 03:44 ET | 7394 | 24.06 |
| 03:46 ET | 9863 | 24.035 |
| 03:48 ET | 8452 | 24.07 |
| 03:50 ET | 13380 | 24.015 |
| 03:51 ET | 24202 | 23.905 |
| 03:53 ET | 28263 | 24.01 |
| 03:55 ET | 21895 | 24.045 |
| 03:57 ET | 39388 | 24.025 |
| 04:00 ET | 267854 | 24.05 |
Nov 12, 2024
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
DJ Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co., from 5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
DJ Beam Therapeutics Is Maintained at Sector Perform by RBC Capital, from 11:10AM ET on Wednesday Nov 06, 2024 by Dow Jones
11:10AM ET on Wednesday Nov 06, 2024 by Dow JonesDJ Beam Therapeutics Raised to Outperform From Market Perform by Leerink Partners, from 7:39AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:39AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Press Release: Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (ASH) Annual Meeting, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Beam Therapeutics Inc | 2.0B | -14.0x | --- |
Genmab A/S | 13.5B | 20.4x | +22.71% |
Galapagos NV | 1.8B | -28.0x | --- |
Catalyst Pharmaceuticals Inc | 2.5B | 17.6x | --- |
BioCryst Pharmaceuticals Inc | 1.5B | -11.6x | --- |
Veracyte Inc | 2.8B | -248.8x | --- |
Company Information
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Contact Information
- Headquarters
- 238 Main StreetCAMBRIDGE, MA, United States 02142
- Phone
- 857-327-8775
- Fax
- 302-655-5049
Executives
- President
- Giuseppe Ciaramella
- Chief Executive Officer, Principal Financial and Accounting Officer, Director
- John Evans
- Chief Medical Officer
- Amy Simon
- Chief Legal Officer and Secretary
- Christine Bellon
- Lead Independent Director
- Mark Fishman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
|---|---|
Revenue (TTM) | $349.6M |
Shares Outstanding | 82.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.72 |
Book Value | $12.02 |
P/E Ratio | -14.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
